efficacyAI Signs Exclusive Software License for MedicascyAI™ a Suite of Deep Learning Algorithms Used to Predict Drug Safety and Efficacy
HARRISBURG, Pa.–(BUSINESS WIRE)–efficacyAI, Inc. announced today that it has recently signed a license agreement with the Georgia Tech Research Corporation granting it exclusive rights to the use of a suite of algorithms called MedicascyAI. This novel artificial intelligence software platform requires only the chemical structure of a small molecule as the input to make actionable…